Survivorship, Radiographic, and Functional Outcomes of the Multihole Revision Acetabular Cup

Sponsor
The Cleveland Clinic (Other)
Overall Status
Terminated
CT.gov ID
NCT03031964
Collaborator
(none)
24
1
61
0.4

Study Details

Study Description

Brief Summary

This study will evaluate patients receiving a multihole revision acetabular implant for total hip arthroplasty (THA) and will be followed for 10 years to collect data on survivorship of the implanted prosthesis.

Condition or Disease Intervention/Treatment Phase
  • Device: revision multihole acetabular cup

Detailed Description

Data will be collected preoperatively, and at the standard of care (SOC) office visits at 4 weeks, 1 year, 2 years, 5 years and 10 years postoperatively. The research coordinator at each site will identify, recruit, and prospectively follow the 60 patients at his/her site. Patient demographics (e.g., age, gender, body mass index (BMI)), comorbidities, reason for revision, Paprosky classification, native femoral head measurement (mm) etc. will be collected preoperatively. The study coordinator will contact patients prior to each visit to ensure patient compliance. At each visit, A-P and cross-lateral radiographic evaluation (i.e., use of Engh classification to quantify osteolysis/loosening) will occur. In addition, patients will be assessed for any complications (e.g., dislocation, emergency department visits, infection, reoperation, etc.). Patients will complete the Hip disability and Osteoarthritis Outcome Score (HOOS) and Veterans Rand 12 (VR-12) forms (including a specific question regarding groin pain) and a pain assessment. In the event that a patient has relocated and/or refuses to return to the office for the 5-year visit, a script will be sent to the patient to have x-rays done and sent to the PI, and questionnaires will be mailed. All data will be entered and maintained in RedCap.

Study Design

Study Type:
Observational
Actual Enrollment :
24 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Survivorship, Clinical and Functional Outcomes of the Multihole Revision Acetabular Cup
Study Start Date :
Dec 1, 2016
Actual Primary Completion Date :
Jan 1, 2022
Actual Study Completion Date :
Jan 1, 2022

Arms and Interventions

Arm Intervention/Treatment
revision multihole acetabular cup

Revision total hip arthroplasty using multihole revision acetabular cup

Device: revision multihole acetabular cup
post market study of multi hole revision acetabular cup
Other Names:
  • Stryker restoration anatomic shell
  • Outcome Measures

    Primary Outcome Measures

    1. survivorship of a multihole revision acetabular cup [10 years]

      evaluate standard of care radiographs for any signs of implant compromise such as loosening or osteolysis

    Secondary Outcome Measures

    1. Clinical outcomes of multihole revision acetabular cup [10 years]

      determine clinical outcomes with VR-12 surveys

    2. functional outcomes of multihole revision acetabular cup [10 years]

      determine functional outcomes with HOOS surveys

    3. assess pain levels in patients who receive multihole revision acetabular cup [10 years]

      determine level of pain with pain assessments

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 85 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    1. Patients requiring revision total hip replacement of the acetabular component or complicated primary total hip replacement.

    2. Femoral stem (either retained or replaced) is a compatible Stryker stem.

    3. Patient is willing to comply with follow-up requirements (e.g. will return for long-term follow-up visits)

    4. Age: 18-85 years

    Exclusion Criteria:
    1. Patient has a BMI > 40

    2. Exclude revision for infection

    3. Patient is undergoing bilateral THA surgery or had prior hip arthroplasty on contralateral side less than 6 months from date of surgery

    4. Patient has history of radiation therapy

    5. Patient has known diagnosis of renal disease

    6. Patient has known diagnosis of osteoporosis

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Cleveland Clinic Cleveland Ohio United States 44195

    Sponsors and Collaborators

    • The Cleveland Clinic

    Investigators

    • Principal Investigator: Carlos Higuera, MD, The Cleveland Clinic

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Carlos Higuera-Rueda, Staff Surgeon, The Cleveland Clinic
    ClinicalTrials.gov Identifier:
    NCT03031964
    Other Study ID Numbers:
    • #16-1030
    First Posted:
    Jan 26, 2017
    Last Update Posted:
    Jan 28, 2022
    Last Verified:
    Jan 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No

    Study Results

    No Results Posted as of Jan 28, 2022